SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-049818
Filing Date
2021-12-27
Accepted
2021-12-27 18:36:40
Documents
2
Period of Report
2021-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7992
2 EX-24 DOCUMENT attachment1.htm EX-24 4480
  Complete submission text file 0000899243-21-049818.txt   13874
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RELAY THERAPEUTICS, INC. 399 BINNEY STREET CAMBRIDGE MA 02139
Business Address
Porter Andy (Reporting) CIK: 0001899340 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39385 | Film No.: 211521697